Bracciano, Italy

Carlo De Luca

This inventor holds 1 USPTO granted patent. Top assignee: Consiglio Nazionale Delle Ricerche. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlo De Luca. Retrieved from https://idiyas.com/inventor/carlo-de-luca-50zhslg8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carlo De Luca: Innovator in Guanidine Derivatives

Introduction

Carlo De Luca is a notable inventor based in Bracciano, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his work on guanidine derivatives. His innovative approach has led to advancements in hypotensive activity, showcasing the potential of these compounds in medical applications.

Latest Patents

Carlo De Luca holds a patent for "Guanidine derivatives having hypotensive activity." This patent includes compositions of guanidine derivatives represented by specific formulas, where R¹ can be hydrogen or optionally substituted cinnamoyl. His work in this area highlights the importance of guanidine derivatives in developing effective treatments for hypertension. He has 1 patent to his name.

Career Highlights

De Luca is affiliated with the National Research Council (Consiglio Nazionale Delle Ricerche), where he has been involved in various research projects. His dedication to scientific inquiry and innovation has positioned him as a key figure in his field. His research not only contributes to academic knowledge but also has practical implications for healthcare.

Collaborations

Throughout his career, Carlo De Luca has collaborated with esteemed colleagues, including Giuliano D Monache and Franco D Monache. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Carlo De Luca's work on guanidine derivatives exemplifies the intersection of innovation and healthcare. His contributions are vital for advancing medical treatments and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…